MRC Global Announces Second Quarter 2023 Results
August 07, 2023 16:15 ET
|
MRC Global
HOUSTON, Aug. 07, 2023 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE: MRC), the leading global distributor of pipe, valves, fittings and infrastructure products and services to diversified energy,...
MRC Global Announces First Quarter 2023 Results
May 08, 2023 16:15 ET
|
MRC Global
HOUSTON, May 08, 2023 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE: MRC), the leading global distributor of pipe, valves, fittings and infrastructure products and services to diversified energy,...
MRC Global Reports Full Year and Fourth Quarter 2022 Results and 2023 Outlook
February 13, 2023 16:15 ET
|
MRC Global
HOUSTON, Feb. 13, 2023 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE: MRC), the leading global distributor of pipe, valves and fittings (PVF) and other infrastructure products and services to...
Magna Announces Fourth Quarter 2022 Results and 2023 Outlook
February 10, 2023 05:00 ET
|
Magna International Inc.
Fourth Quarter 2022 Highlights Sales increased 5% to $9.6 billionExcluding foreign currency translation sales increased 13%, compared to a global light vehicle production increase of 5%Diluted...
Magna Announces Date for Q4 & Year End 2022 Results and 2023 Outlook Conference Call
January 10, 2023 16:58 ET
|
Magna International Inc.
AURORA, Ontario, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX:MG) (NYSE:MGA) MAGNA ANNOUNCES DATE FOR Q4 & YEAR END 2022 RESULTS and 2023 OUTLOOK CONFERENCE CALL FRIDAY –...
Travere Therapeutics Provides Corporate Update and 2023 Outlook
January 09, 2023 07:00 ET
|
Travere Therapeutics, Inc.
Company well-positioned for potential FDA Subpart H approval and commercial launch of sparsentan for IgA nephropathy (IgAN) in 1Q23, followed by potential EMA approval in second half of 2023 ...
VIRBAC : Perspectives 2023
December 19, 2022 02:30 ET
|
Virbac
Alors que nous poursuivons l'exécution de notre plan stratégique 2030, nous avons pris la décision de continuer d'accélérer en 2023 sur deux dimensions clés : la R&D et les investissements. Afin...
VIRBAC : 2023 Outlook
December 19, 2022 02:30 ET
|
Virbac
As we continue to execute our 2030 strategic plan, we have made the decision to continue to accelerate in 2023 on two key dimensions : R&D and capital expenditures. In order to maximize the...